Mladen Vidovich is a Cardiology physician affiliated with University of Illinois Chicago. OpenAlex indexes 188 publications with 2,183 citations (h-index 25); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1740 W Taylor St
Dept 3462
Chicago, IL 606127232
Telephone
312-704-2885Registry record last updated 11 Jun 2008.
Clinical trials
- SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI
Sponsor: Jesse Brown VA Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BIOTRONIK INC.Program year20251 payment
- Boston Scientific CorporationProgram year20253 payments
- Teleflex LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.3%Statin25%Atorvastatin Calcium68%Rosuvastatin Calcium26%Pravastatin Sodium7%Part D<11 patientsBeta blocker17.8%Carvedilol58%Metoprolol Succinate42%Part D≥23 patients+ 9 more classes in this area
Metabolism & gastrointestinal
8.7%SGLT2 inhibitor5.3%Jardiance69%Farxiga31%Part D<11 patientsGLP-1 receptor agonist3.4%Ozempic52%Rybelsus48%Part D<11 patientsBlood & clotting
8%P2Y12 inhibitor4%Clopidogrel100%Part D<11 patientsFactor Xa inhibitor4%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
European Heart Journal - Cardiovascular Pharmacotherapy
2024 - SCAI Expert Consensus Statement on Percutaneous Coronary Intervention Without On-Site Surgical Backup
JACC: Cardiovascular Interventions
2023 - Team-Based Coaching Intervention to Improve Contrast-Associated Acute Kidney Injury
Clinical Journal of the American Society of Nephrology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Jerry Krishnan, MD
University of Illinois Chicago
John Daugirdas, MD
University of Illinois Chicago
Itishree Trivedi, MD
University of Illinois Chicago
Victor Gordeuk, MD
University of Illinois Chicago
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”